Endometrial cancer prognosis correlates with the expression of L1CAM and miR34a biomarkers
Abstract Background Patients with endometrial cancer (EC) and presumably with good prognosis may develop a recurrence indicating that the classification of this tumor is still not definitive and that new markers are needed to identify a subgroup at risk of relapse. The cell adhesion molecule L1CAM i...
Main Authors: | Giacomo Corrado, Valentina Laquintana, Rossella Loria, Mariantonia Carosi, Laura de Salvo, Isabella Sperduti, Ashanti Zampa, Lucia Cicchillitti, Giulia Piaggio, Giuseppe Cutillo, Rita Falcioni, Enrico Vizza |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-018-0816-1 |
Similar Items
-
Serum DNA integrity index as a potential molecular biomarker in endometrial cancer
by: Enrico Vizza, et al.
Published: (2018-01-01) -
The Clinical Significance of DJ1 and L1CAM Serum Level Monitoring in Patients with Endometrial Cancer
by: Marketa Bednarikova, et al.
Published: (2021-06-01) -
Diagnostic and Prognostic Values of Serum EpCAM, TGM2, and HE4 Levels in Endometrial Cancer
by: Ting Lan, et al.
Published: (2020-09-01) -
Correction to: Serum DNA integrity index as a potential molecular biomarker in endometrial cancer
by: Enrico Vizza, et al.
Published: (2018-02-01) -
CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis
by: Anna Torres, et al.
Published: (2019-04-01)